These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12824095)

  • 21. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
    Topol EJ; Easton D; Harrington RA; Amarenco P; Califf RM; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Granett J; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Sigmon K; Pieper K; Vallee M; Willerson JT;
    Circulation; 2003 Jul; 108(4):399-406. PubMed ID: 12874182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.
    Meade TW; Roderick PJ; Brennan PJ; Wilkes HC; Kelleher CC
    Thromb Haemost; 1992 Jul; 68(1):1-6. PubMed ID: 1514166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
    Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ;
    Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment and the incidence of angina pectoris.
    Knottenbelt C; Brennan PJ; Meade TW;
    Arch Intern Med; 2002 Apr; 162(8):881-6. PubMed ID: 11966338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.
    Falanga A; Levine MN; Consonni R; Gritti G; Delaini F; Oldani E; Julian JA; Barbui T
    Thromb Haemost; 1998 Jan; 79(1):23-7. PubMed ID: 9459316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin and aspirin for prevention of IHD.
    Zamorski MA
    J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
    McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
    J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
    Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
    Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy use and the risk of venous thromboembolic events in the Raloxifene Use for the Heart (RUTH) trial.
    Duvernoy CS; Yeo AA; Wong M; Cox DA; Kim HM
    J Womens Health (Larchmt); 2010 Aug; 19(8):1459-65. PubMed ID: 20626269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery.
    Huynh T; Théroux P; Bogaty P; Nasmith J; Solymoss S
    Circulation; 2001 Jun; 103(25):3069-74. PubMed ID: 11425770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of secondary prevention practice in poststroke and coronary heart disease patients.
    Vaněk J; Mayer O; Seidlerová J; Bruthans J; Kielbergerová L; Wohlfahrt P; Krajčoviechová A; Filipovský J; Cífková R
    Public Health; 2016 Aug; 137():64-72. PubMed ID: 26996311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings.
    Richards M; Meade TW; Peart S; Brennan PJ; Mann AH
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):269-72. PubMed ID: 9069483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The low incidence of coronary thrombosis: a poor target for long-term anticoagulants.
    Eliot RS; Streiff RR
    Geriatrics; 1971 Jan; 26(1):152-7. PubMed ID: 4099550
    [No Abstract]   [Full Text] [Related]  

  • 34. Compliance to multiple interventions in a high risk population.
    Pettinger MB; Waclawiw MA; Davis KB; Thomason T; Garg R; Griffin B; Egan DA
    Ann Epidemiol; 1999 Oct; 9(7):408-18. PubMed ID: 10501408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin for refractory chronic cluster headache: a randomized pilot study.
    Hakim SM
    Headache; 2011 May; 51(5):713-25. PubMed ID: 21395575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of warfarin in arterial thrombosis: evidence from a vascular prosthesis model in rats.
    Reyers I; de Gaetano G; Donati MB
    Thromb Haemost; 1983 Dec; 50(4):821-3. PubMed ID: 6665763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary prophylaxis with warfarin for recurrent thrombosis in a patient with Glanzmann thrombasthenia and F5 G1691A.
    Rezende SM
    Br J Haematol; 2012 Jan; 156(1):144. PubMed ID: 21848888
    [No Abstract]   [Full Text] [Related]  

  • 38. The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.
    Heinonen OP; Huttunen JK; Manninen V; Mänttäri M; Koskinen P; Tenkanen L; Frick MH
    J Intern Med; 1994 Jan; 235(1):41-9. PubMed ID: 8283158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study.
    Hertzberg V; Chimowitz M; Lynn M; Chester C; Asbury W; Cotsonis G
    Clin Trials; 2008; 5(1):23-30. PubMed ID: 18283076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?
    Petitti DB
    Ann Epidemiol; 1994 Mar; 4(2):115-8. PubMed ID: 8205277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.